Hill-Rom Holdings ROA 2006-2018 | HRC

Current and historical return on assets (ROA) values for Hill-Rom Holdings (HRC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Hill-Rom Holdings ROA for the three months ending September 30, 2018 was 7.23%.
Hill-Rom Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.25B $4.36B 5.67%
2018-06-30 $0.23B $4.47B 5.14%
2018-03-31 $0.19B $4.51B 4.27%
2017-12-31 $0.20B $4.46B 4.39%
2017-09-30 $0.13B $4.53B 3.02%
2017-06-30 $0.12B $4.48B 2.67%
2017-03-31 $0.16B $4.47B 3.62%
2016-12-31 $0.14B $4.14B 3.39%
2016-09-30 $0.12B $4.26B 2.92%
2016-06-30 $0.06B $4.24B 1.44%
2016-03-31 $0.04B $4.24B 0.98%
2015-12-31 $0.04B $4.27B 1.31%
2015-09-30 $0.05B $4.46B 1.95%
2015-06-30 $0.08B $1.76B 4.72%
2015-03-31 $0.09B $1.71B 5.33%
2014-12-31 $0.06B $1.74B 3.70%
2014-09-30 $0.06B $1.75B 3.88%
2014-06-30 $0.07B $1.49B 4.64%
2014-03-31 $0.07B $1.52B 4.40%
2013-12-31 $0.09B $1.53B 5.96%
2013-09-30 $0.10B $1.59B 6.57%
2013-06-30 $0.11B $1.55B 6.78%
2013-03-31 $0.11B $1.57B 7.06%
2012-12-31 $0.11B $1.62B 7.61%
2012-09-30 $0.12B $1.63B 8.82%
2012-06-30 $0.15B $1.30B 11.34%
2012-03-31 $0.12B $1.29B 9.70%
2011-12-31 $0.13B $1.22B 10.34%
2011-09-30 $0.13B $1.30B 10.50%
2011-06-30 $0.12B $1.30B 9.58%
2011-03-31 $0.15B $1.28B 12.04%
2010-12-31 $0.14B $1.22B 11.46%
2010-09-30 $0.13B $1.25B 10.29%
2010-06-30 $0.10B $1.23B 8.27%
2010-03-31 $0.09B $1.22B 7.47%
2009-12-31 $-0.40B $1.20B -33.54%
2009-09-30 $-0.41B $1.23B -31.24%
2009-06-30 $-0.41B $1.17B -28.85%
2009-03-31 $-0.41B $1.17B -26.81%
2008-12-31 $0.08B $1.63B 5.13%
2008-09-30 $0.12B $1.69B 6.49%
2008-06-30 $0.14B $1.60B 7.39%
2008-03-31 $0.16B $1.64B 7.76%
2007-12-31 $0.18B $2.17B 8.78%
2007-09-30 $0.19B $2.12B 9.29%
2007-06-30 $0.21B $2.07B 10.42%
2007-03-31 $0.23B $2.04B 11.00%
2006-12-31 $0.23B $2.00B 10.88%
2006-09-30 $0.22B $1.95B 10.36%
2006-06-30 $-0.08B $2.19B -3.45%
2006-03-31 $-0.09B $2.13B -4.13%
2005-12-31 $-0.09B $2.26B -4.22%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.061B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.396B 19.07
Abbott Laboratories (ABT) United States $121.907B 24.70
Stryker (SYK) United States $62.115B 23.41
Boston Scientific (BSX) United States $50.107B 25.32
Baxter (BAX) United States $33.967B 21.93
Zimmer Biomet Holdings (ZBH) United States $22.913B 14.86
Smith & Nephew SNATS (SNN) United Kingdom $16.016B 0.00
ResMed (RMD) United States $14.484B 27.62
Perrigo (PRGO) Ireland $8.621B 13.09
Bio-Rad Laboratories (BIO) United States $8.038B 51.40
Canopy Growth (CGC) Canada $7.963B 0.00
Aurora Cannabis (ACB) Canada $5.941B 32.42
Haemonetics (HAE) United States $5.495B 48.32
Hutchison China MediTech (HCM) China $5.011B 0.00
Insulet (PODD) United States $4.690B 0.00
ICU Medical (ICUI) United States $4.600B 25.63
GW Pharmaceuticals (GWPH) United Kingdom $3.898B 0.00
Agios Pharmaceuticals (AGIO) United States $3.709B 0.00
National Vision Holdings (EYE) United States $3.224B 62.36
Neogen (NEOG) United States $3.190B 48.31
NuVasive (NUVA) United States $3.045B 28.33
Quidel (QDEL) United States $2.390B 31.16
Aphria (APHA) $2.383B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.455B 20.60
AtriCure (ATRC) United States $1.189B 0.00
Cardiovascular Systems (CSII) United States $1.007B 1450.50
VAREX IMAGING (VREX) United States $0.933B 18.74
Meridian Bioscience (VIVO) United States $0.816B 26.01
Surmodics (SRDX) United States $0.775B 118.39
OraSure Technologies (OSUR) United States $0.771B 43.38
Eagle Pharmaceuticals (EGRX) United States $0.738B 23.67
PetIQ (PETQ) United States $0.737B 20.93
MacroGenics (MGNX) United States $0.702B 0.00
Cerus (CERS) United States $0.685B 0.00
Lantheus Holdings (LNTH) United States $0.604B 18.68
Omeros (OMER) United States $0.569B 0.00
Owens & Minor (OMI) United States $0.550B 6.22
Insys Therapeutics (INSY) United States $0.531B 0.00
LeMaitre Vascular (LMAT) United States $0.510B 25.05
NanoString Technologies (NSTG) United States $0.478B 0.00
TG Therapeutics (TGTX) United States $0.429B 0.00
Evolus (EOLS) United States $0.373B 0.00
Quanterix (QTRX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.11
Cytosorbents (CTSO) United States $0.287B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.254B 0.00
Rockwell Medical (RMTI) United States $0.230B 0.00
Surface Oncology (SURF) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.197B 265.75
Bovie Medical (BVX) United States $0.189B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.138B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.107B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.53
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Valeritas Holdings (VLRX) United States $0.017B 0.00
Senestech (SNES) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00